Journal reference: Wang, W., Wang, Q., Qi, X., et al
How to spot misleading GLP-1 patch marketing Red flags: any claim of containing "semaglutide" or "tirzepatide" (illegal without a prescription), before-and-after photos without clinical trial context, specific weight-loss promises ("lose 12+ lbs per month"), language like "Nature's Ozempic" or "works like Wegovy," and any implication of FDA review
Justifiably, therapies targeting oxidative stress are currently under investigation
It is a state-of-the-art system that solves not only todays but also the challenges of tomorrow
Caution is advised for those with gastrointestinal obstruction or severe gastroparesis
Secondary outcomes included all-cause mortality, cardiovascular mortality, hospitalisation for heart failure, a kidney composite endpoint and serious adverse events